Rho-kinase inhibitor may exert a role in preventing cardiac hypertrophy, independent of antihypertensive effects.
Pan
Min
M
Jing
Hong-Mei
HM
Zhu
Jian-Hua
JH
Liu
Zhi-Hua
ZH
Jiang
Wen-Ping
WP
Yang
Xiang-Jun
XJ
D000577:Amides / Q000008:administration & dosage*; D000818:Animals; D000959:Antihypertensive Agents / Q000008:administration & dosage; D001794:Blood Pressure / Q000187:drug effects*; D006332:Cardiomegaly / Q000201:enzymology* / Q000517:prevention & control*; D004791:Enzyme Inhibitors / Q000008:administration & dosage; D047908:Intracellular Signaling Peptides and Proteins / Q000037:antagonists & inhibitors* / Q000378:metabolism*; D008955:Models, Cardiovascular; D017346:Protein Serine-Threonine Kinases / Q000037:antagonists & inhibitors* / Q000378:metabolism*; D011725:Pyridines / Q000008:administration & dosage*; D051381:Rats; D054460:rho-Associated Kinases
D000577:Amides; D000959:Antihypertensive Agents; D004791:Enzyme Inhibitors; D047908:Intracellular Signaling Peptides and Proteins; D011725:Pyridines; C108830:Y 27632; D017346:Protein Serine-Threonine Kinases; D054460:rho-Associated Kinases